What Diadema Partners LP reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 2026172 · Filed Aug 14, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 349.2K |
| +249.2% |
| $46.5M |
| 5.9% |
| 600K | New | $34.6M | 4.4% |
| 252.4K | +152.4% | $33.6M | 4.3% |
UTHRUNITED THERAPEUTICS Corp | 53K | +94.1% | $28.7M | 3.6% |
RVMDRevolution Medicines, Inc. | 139.2K | +72.1% | $26.1M | 3.3% |
ABVXAbivax S.A. | 163.6K | +115.5% | $21.6M | 2.7% |
COGTCogent Biosciences, Inc. | 493.7K | +52.9% | $19.1M | 2.4% |
| 330.6K | New | $19M | 2.4% |
BRIDGEBIO PHARMA INCNOTE 1.750% 3/0 | 250K | ±0% | $18.6M | 2.4% |
| 206.3K | +30.2% | $17.9M | 2.3% |
BMRNBioMarin Pharmaceutical Inc | 312.8K | +111.1% | $17.9M | 2.3% |
VKTXViking Therapeutics, Inc. | 441.8K | −15.9% | $17.2M | 2.2% |
| 149.7K | New | $17.2M | 2.2% |
| 100K | New | $15.7M | 2% |
| 299K | ±0% | $13.8M | 1.7% |
| 350.5K | New | $13.7M | 1.7% |
| 60K | New | $13M | 1.6% |
| 534.4K | −14.3% | $12.9M | 1.6% |
| 860.2K | New | $12.5M | 1.6% |
| 10K | New | $12M | 1.5% |
| 105.4K | ±0% | $11.9M | 1.5% |
EWTXEdgewise Therapeutics, Inc. | 272.2K | New | $11.1M | 1.4% |
| 235.4K | −5.8% | $10.8M | 1.4% |
| 100K | New | $9.3M | 1.2% |
KODKodiak Sciences Inc. | 218.1K | +13.0% | $8.5M | 1.1% |
IMCRImmunocore Holdings plc | 254.9K | +31.9% | $8.1M | 1% |
| 329.3K | ±0% | $7.9M | 1% |
| 50K | New | $7.8M | 1% |
| 696.3K | +238.8% | $7.7M | 1% |
| 196.7K | +98,250.0% | $7.7M | 1% |
FDMT4D Molecular Therapeutics, Inc. | 571.1K | New | $7.6M | 1% |
| 100K | −37.3% | $7M | 0.9% |
| 200K | New | $6.9M | 0.9% |
RCUSArcus Biosciences, Inc. | 223.8K | −6.0% | $6.9M | 0.9% |
| 193.7K | New | $6.7M | 0.8% |
| 633.8K | +449.7% | $5.9M | 0.8% |
| 400K | +33.3% | $5.9M | 0.7% |
| 146.9K | −40.5% | $5.7M | 0.7% |
| 200K | +100.0% | $5.6M | 0.7% |
| 100K | New | $5.6M | 0.7% |
JNJJohnson & Johnson | 22K | −59.1% | $5.6M | 0.7% |
| 502.5K | +9.3% | $5.6M | 0.7% |
| 200.1K | New | $4.9M | 0.6% |
NVONovo Nordisk a S | 100K | +586.0% | $4.8M | 0.6% |
| 317K | ±0% | $4.7M | 0.6% |
| 307K | New | $4.5M | 0.6% |
CRVSCorvus Pharmaceuticals, Inc. | 294.8K | +20.4% | $4.4M | 0.6% |
RLAYRelay Therapeutics, Inc. | 230.7K | New | $4.3M | 0.5% |
| 75.7K | New | $4.2M | 0.5% |
| 170.1K | New | $4.1M | 0.5% |
| 124K | New | $3.8M | 0.5% |
| 792.6K | New | $3.7M | 0.5% |
ZYMEZymeworks Inc. | 142.1K | ±0% | $3.7M | 0.5% |
| 10K | New | $3.6M | 0.5% |
BIOABioAge Labs, Inc. | 146.3K | +143.9% | $3.6M | 0.5% |
TSHATaysha Gene Therapies, Inc. | 522.6K | New | $3.6M | 0.4% |
| 200K | ±0% | $3.4M | 0.4% |
| 86K | New | $3.2M | 0.4% |
| 53.1K | ±0% | $3.1M | 0.4% |
NRIXNurix Therapeutics, Inc. | 121.5K | New | $2.9M | 0.4% |
| 200K | New | $2.9M | 0.4% |
| 48.9K | New | $2.8M | 0.4% |
CRBPCorbus Pharmaceuticals Holdings, Inc. | 301.3K | −31.5% | $2.8M | 0.4% |
INDVIndivior Pharmaceuticals, Inc. | 67.5K | −5.4% | $2.8M | 0.4% |
IVAInventiva S.A. | 740.8K | +110.2% | $2.7M | 0.3% |
| 55.9K | ±0% | $2.7M | 0.3% |
ORKAOruka Therapeutics, Inc. | 27.8K | New | $2.6M | 0.3% |
PCVXVaxcyte, Inc. | 45.1K | +79.8% | $2.6M | 0.3% |
| 30K | −85.0% | $2.6M | 0.3% |
RLMDRelmada Therapeutics, Inc. | 361.4K | +79.9% | $2.5M | 0.3% |
VERAVera Therapeutics, Inc. | 57.6K | New | $2.5M | 0.3% |
| 50K | New | $2.1M | 0.3% |
| 20K | +13.0% | $2.1M | 0.3% |
| 353.2K | ±0% | $2M | 0.3% |
| 59.7K | New | $2M | 0.3% |
| 133.4K | +25.5% | $2M | 0.3% |
CTNMContineum Therapeutics, Inc. | 119.7K | New | $2M | 0.2% |
BCYCBicycle Therapeutics PLC | 462.7K | −2.9% | $2M | 0.2% |
GLUEMonte Rosa Therapeutics, Inc. | 78.4K | −58.1% | $1.9M | 0.2% |
| 50.9K | New | $1.9M | 0.2% |
VRDNViridian Therapeutics, Inc. | 100K | New | $1.8M | 0.2% |
MGNXMacrogenics Inc | 374.4K | −37.6% | $1.7M | 0.2% |
PRQRProQR Therapeutics N.V. | 926K | +414.2% | $1.7M | 0.2% |
| 200K | New | $1.7M | 0.2% |
SPRBSpruce Biosciences, Inc. | 30K | +200.0% | $1.6M | 0.2% |
ARDXArdelyx, Inc. | 303K | New | $1.5M | 0.2% |
CUECue Biopharma, Inc. | 48.4K | New | $1.5M | 0.2% |
MLYSMineralys Therapeutics, Inc. | 56.3K | +113.9% | $1.5M | 0.2% |
| 106.3K | ±0% | $1.5M | 0.2% |
| 100K | New | $1.5M | 0.2% |
PRTAProthena Corp Public Ltd Co | 149.5K | New | $1.5M | 0.2% |
VYGRVoyager Therapeutics, Inc. | 413.6K | −2.4% | $1.4M | 0.2% |
UNCYUnicycive Therapeutics, Inc. | 303.7K | +186.3% | $1.4M | 0.2% |
PHATPhathom Pharmaceuticals, Inc. | 130K | +137.8% | $1.4M | 0.2% |
| 200K | +59.7% | $1.4M | 0.2% |
SYRESpyre Therapeutics, Inc. | 15K | New | $1.3M | 0.2% |
HELPHelus Pharma Inc. | 200K | New | $1.3M | 0.2% |
| 167.5K | ±0% | $1.3M | 0.2% |
| 400K | New | $1.3M | 0.2% |
EQEquillium, Inc. | 400.3K | −7.7% | $1.3M | 0.2% |
| 388.2K | New | $1.2M | 0.1% |
XERSXeris Biopharma Holdings, Inc. | 132.7K | ±0% | $1.1M | 0.1% |
PHVSPharvaris N.V. | 29.3K | ±0% | $1M | 0.1% |
HRMYHarmony Biosciences Holdings, Inc. | 26.9K | −71.1% | $978.1K | 0.1% |
RNACCartesian Therapeutics, Inc. | 87.1K | New | $907.1K | 0.1% |
| 214.6K | New | $892.7K | 0.1% |
RIGLRigel Pharmaceuticals Inc | 22.8K | New | $892.6K | 0.1% |
SMMTSummit Therapeutics Inc. | 60K | New | $874.2K | 0.1% |
PGENPrecigen, Inc. | 135.3K | +144.7% | $771.2K | 0.1% |
DFTXDefinium Therapeutics, Inc. | 15.5K | New | $726.8K | 0.1% |
PTHSPelthos Therapeutics Inc. | 24.8K | ±0% | $700.1K | 0.1% |
PEPGPepGen Inc. | 373.3K | +147.3% | $671.9K | 0.1% |
| 100K | New | $661K | 0.1% |
| 150K | ±0% | $525K | 0.1% |
| 7.3K | New | $518.7K | 0.1% |
ELVNEnliven Therapeutics, Inc. | 10K | +3,981.6% | $507.5K | 0.1% |
CNTBConnect Biopharma Holdings Ltd | 197K | −1.8% | $468.8K | 0.1% |
LRMRLarimar Therapeutics, Inc. | 146.6K | −12.0% | $447.2K | 0.1% |
| 112.1K | New | $438.3K | 0.1% |
| 100K | New | $391K | 0.1% |
CLRBCellectar Biosciences, Inc. | 138.3K | New | $384.6K | 0.1% |
FHTXFoghorn Therapeutics Inc. | 66.9K | −16.3% | $326.5K | 0.1% |
AYTUAytu Biopharma, Inc | 148.5K | −57.9% | $319.4K | 0.1% |
OCGNOcugen, Inc. | 200K | ±0% | $306K | 0.1% |
| 275.2K | +266.0% | $302.7K | 0.1% |
URGNUroGen Pharma Ltd. | 7.1K | −69.2% | $262.6K | 0.1% |
AMGNAmgen Inc | 102.7K | New | $214.6K | 0.1% |
HRTXHeron Therapeutics, Inc. | 458.7K | New | $195.8K | 0.1% |
TLPHTalphera, Inc. | 153.6K | ±0% | $158.2K | 0.1% |
ANNXAnnexon, Inc. | 27.5K | −79.3% | $157.1K | 0.1% |
MNPRMonopar Therapeutics | 1.6K | ±0% | $150.9K | 0.1% |
LAKELakeland Industries Inc | 14.1K | New | $150.8K | 0.1% |
UPBUpstream Bio, Inc. | 19.1K | −11.6% | $132.1K | 0.1% |
MGTXMeiraGTx Holdings plc | 8.4K | New | $113.1K | 0.1% |
JATTJATT II Acquisition Corp. | 9K | New | $102.5K | 0.1% |
KLRAKailera Therapeutics, Inc. | 3.6K | New | $79.8K | 0.1% |
MNKDMannkind Corp | 16K | −91.4% | $68.2K | 0.1% |
ENTXEntera Bio Ltd. | 23.3K | ±0% | $41.2K | 0.1% |
SPRYARS Pharmaceuticals, Inc. | 4.9K | New | $38.9K | 0.1% |
APREAprea Therapeutics, Inc. | 44.9K | New | $36K | 0.1% |
TVRDTvardi Therapeutics, Inc. | 16.6K | New | $31.6K | 0.1% |
| 57.7K | New | $13K | 0.1% |
NXTCNextCure, Inc. | 7.7K | New | $12.4K | 0.1% |
| 12.5K | ±0% | $7.5K | 0.1% |
| 500 | New | $6.8K | 0.1% |
| 1K | ±0% | $3.2K | 0.1% |
| 100 | New | $1.8K | 0.1% |
| 6 | New | $6 | 0% |
